Medetomidine Hydrochloride, Vatinoxan Hydrochloride Patent Expiration
About Veterinary Medetomidine Hydrochloride, Vatinoxan Hydrochloride
Medetomidine Hydrochloride, Vatinoxan Hydrochloride is used in a drug marketed by 1 company: Dechra Ltd.
Other drugs containing Medetomidine Hydrochloride, Vatinoxan Hydrochloride are: Zenalpha .
Veterinary Medetomidine Hydrochloride, Vatinoxan Hydrochloride Patents
Given below is the list of patents protecting Medetomidine Hydrochloride, Vatinoxan Hydrochloride, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Zenalpha | US10058538 | 08 Nov, 2035 | DECHRA, LTD. |
Medetomidine Hydrochloride, Vatinoxan Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List